This grant, offered by the NIH, supports Small Business Innovation Research (SBIR) projects to develop novel non-invasive diagnostic and screening tools for endometriosis, adenomyosis, and uterine fibroids. The core purpose is to improve gynecologic health by fostering partnerships that commercialize advanced technology-based approaches. Projects will leverage bio-chips, microfluidics, and mobile health to enhance diagnostic accuracy and reduce delays. The ultimate goal is to create safe, effective, and easily integrated techniques or devices. Solutions should prioritize reliability, robustness, simplicity, and address regulatory requirements, improved access for underserved areas, and cost-effectiveness.
Opportunity ID: 327983
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HD-21-020 |
| Funding Opportunity Title: | Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 02, 2020 |
| Last Updated Date: | Jul 02, 2020 |
| Original Closing Date for Applications: | Dec 10, 2020 |
| Current Closing Date for Applications: | Dec 10, 2020 |
| Archive Date: | Jan 15, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the Non-invasive Diagnostics in Gynecologic Health RFA is to support SBIR projects to small businesses using advanced technologies (e.g., bio-chips, microfluidics, and mobile technologies) to develop novel or improved diagnostic and/or screening approaches, tools, or devices for endometriosis, adenomyosis, and/or uterine fibroids. The ultimate goal of the program is to improve human gynecologic health by fostering partnerships between small businesses and experts in diverse fields of research to commercialize approaches that improve accuracy and decrease the delay in diagnosis and/or screening of the named gynecologic conditions. These projects will also encourage collaborations with investigators and small businesses who have not yet applied their expertise to gynecologic research, thereby expanding the potential scientific insight and investigational toolkit available to these projects. It is anticipated that, through rigorous collaborative R and D efforts, safe and effective techniques, instruments, and devices can be developed for use in the evaluation and diagnosis of women with endometriosis, uterine fibroids, or adenomyosis. Within the disorders noted above, projects that address a specific and well-characterized clinical need will be considered of high potential impact. The technologies developed with funding through this FOA are expected to be integrated systems or, if they are novel components, to be easily integrated into existing systems. Some other technical features that are expected are the following: reliability, robustness, safety, simplicity, reliance on the appropriate baseline information, contextual awareness, and inclusion of software to support decision-making where appropriate. Proposed tools and technologies should incorporate existing standards and consider regulatory requirements where appropriate. In addition, improved access to underserved areas, and cost-effectiveness should be highlighted. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-21-020.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262422 | Nov 10, 2020 | Dec 10, 2020 | View |
Package 1
Mandatory forms
327983 RR_SF424_2_0-2.0.pdf
327983 PHS398_CoverPageSupplement_5_0-5.0.pdf
327983 RR_OtherProjectInfo_1_4-1.4.pdf
327983 PerformanceSite_2_0-2.0.pdf
327983 RR_KeyPersonExpanded_2_0-2.0.pdf
327983 RR_Budget_1_4-1.4.pdf
327983 PHS398_ResearchPlan_4_0-4.0.pdf
327983 SBIR_STTR_Information_1_3-1.3.pdf
327983 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327983 RR_SubawardBudget30_1_4-1.4.pdf
327983 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
